Intensity of Statin Therapy in Relation to Myocardial Ischemia, Troponin T Release, and Clinical Cardiac Outcome in Patients Undergoing Major Vascular Surgery

Journal of the American College of Cardiology

Volumn 50, Issue 17, 2007, Pages 1649-1656

  Feringa, Harm H H ^a   Schouten, Olaf ^a   Karagiannis, Stefanos E ^a   Brugts, Jasper ^a   Elhendy, Abdou ^b   Boersma, Eric ^a   Vidakovic, Radosav ^a   van Sambeek, Marc R H M ^a   Noordzij, Peter G ^a   Bax, Jeroen J ^c   Poldermans, Don ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b MARSHFIELD CLINIC   (United States)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; FLUINDOSTATIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN; TROPONIN T;

ADULT; AGED; ARTICLE; CARDIOVASCULAR SURGERY; CONTROLLED STUDY; DRUG MEGADOSE; ELECTROCARDIOGRAPHY; FEMALE; HEART DEATH; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART RATE VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN SECRETION; TREATMENT OUTCOME;

AGED; BIOLOGICAL MARKERS; CHOLESTEROL, LDL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART RATE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MULTIVARIATE ANALYSIS; MYOCARDIAL ISCHEMIA; OUTCOME ASSESSMENT (HEALTH CARE); PROSPECTIVE STUDIES; TROPONIN T; VASCULAR SURGICAL PROCEDURES;

EID: 35248817952     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.06.046     Document Type: Article

References (25)

1. Mangano D.T. Adverse outcomes after surgery in the year 2001-a continuing odyssey. Anesthesiology 88 (1998) 561-564
2. Mangano D.T., Browner W.S., Hollenberg M., et al. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. N Engl J Med 323 (1990) 1781-1788
3. Durazzo A.E., Machado F.S., Ikeoka D.T., et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg 39 (2004) 967-975
4. Poldermans D., Bax J.J., Kertai M.D., et al. Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation 107 (2003) 1848-1851
5. Lindenauer K., Pekow P., Wang K., et al. Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery. JAMA 291 (2004) 2092-2099
6. Cannon C.P. The IDEAL cholesterol: lower is better. JAMA 294 (2005) 2492-2494
7. Crisby M., Nordin-Fredriksson G., Shah P.K., et al. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization. Circulation 103 (2001) 926-933
8. Welzig C.M., Shin D.G., Park H.J., et al. Lipid lowering by pravastatin increases parasympathetic modulation of heart rate: Galpha(i2), a possible molecular marker for parasympathetic responsiveness. Circulation 108 (2003) 2743-2746
9. Kop W.J., Verdino R.J., Gottdiener J.S., et al. Changes in heart rate and heart rate variability before ambulatory ischemic events. J Am Coll Cardiol 38 (2001) 742-749
10. U.S. Food and Drug Administration. Maximum Recommended Therapeutic Dose Database. Available at: http://www.fda.gov/cder/Offices/OPS_IO/MRTD.htm. Accessed September 1, 2006.
11. Rubin D.B. Estimating causal effects from large data sets using propensity scores. Ann Intern Med 127 (1997) 535-540
12. Jones S.P., and Lefer D.J. Cardioprotective actions of acute HMG-CoA reductase inhibition in the setting of myocardial infarction. Acta Physiol Scand 173 (2001) 139-143
13. Bountioukos M., Rizzello V., Krenning B.J., et al. Effect of atorvastatin on myocardial contractile reserve assessed by tissue Doppler imaging in moderately hypercholesterolemic patients without heart disease. Am J Cardiol 92 (2003) 613-616
14. Shepherd J., Cobbe S.M., Ford I., et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 333 (1995) 1301-1307
15. Sacks F.M., Pfeffer M.A., Moye L.A., et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 335 (1996) 1001-1009
16. LIPID Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 339 (1998) 1349-1357
17. Heart Protection Study Collaborative Group. MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360 (2002) 7-22
18. ASTEROID Investigators. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA 295 (2006) 1556-1565
19. Pehlivanidis A.N., Athyros V.G., Demitriadis D.S., et al. Heart rate variability after long-term treatment with atorvastatin in hypercholesterolaemic patients with or without coronary artery disease. Atherosclerosis 157 (2001) 463-469
20. MADIT-II Research Group. Reduction in ventricular tachyarrhythmias with statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. J Am Coll Cardiol 47 (2006) 769-773
21. Eagle K.A., Berger P.B., Calkins H., et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol 39 (2002) 542-553
22. Hertzer N.R., Beven E.G., Young J.R., et al. Coronary artery disease in peripheral vascular patients. A classification of 1000 coronary angiograms and results of surgical management. Ann Surg 199 (1984) 223-233
23. Boersma E., Kertai M.D., Schouten O., et al. Perioperative cardiovascular mortality in noncardiac surgery: validation of the Lee cardiac risk index. Am J Med 118 (2005) 1134-1141
24. Adult Treatment Panel III. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. JAMA 285 (2001) 2486-2497
25. De Backer G., Ambrosioni E., Borch-Johnsen K., et al. European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 24 (2003) 1601-1610